Compare 10X Genomics Inc (TXG) vs Western Digital Corp (WDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
10X Genomics Inc vs Western Digital Corp — how do they compare? 10X Genomics Inc trades at $47.2 (market cap $5.48B), while Western Digital Corp trades at $555.48 (market cap $168.00B). The key difference: Western Digital Corp is far larger — about 30.7× 10X Genomics Inc's market cap, and Western Digital Corp pays a 0.12% dividend while 10X Genomics Inc pays none. Which is the better fit depends on your goals.
| TXG | WDC | |
|---|---|---|
Market Cap | $5.48B | $168.00B |
Sector | Health | Technology |
52-Week High | $45.80 | $746.23 |
52-Week Low | $11.34 | $67.06 |
Enterprise Value | $5.02B | $166.35B |
Dividend Yield | — | 0.12% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TXG trades at $47.20, up 7.91% on the day, with a bullish technical signal from moving averages. The company reported Q1 2026 revenue that beat estimates, and net losses have narrowed significantly from -$255M in 2023 to -$44M in 2025. Operating cash flow turned strongly positive at $136M in 2025. Recent developments include the acquisition of Proteintech Genomics and a collaboration with Cleveland Clinic on bladder cancer diagnostics.
The outlook is mixed; improving fundamentals and strategic expansions support growth, but persistent net losses and a high EV/EBITDA of 133.91 pose valuation risks. Analyst consensus is divided with a $39.14 price target below the current price, indicating caution despite a majority buy/hold ratings.
Western Digital (WDC) trades at $548.07, up 14.85% over 24 hours, reflecting strong momentum in memory stocks. The stock exhibits a bearish technical signal but has beaten earnings estimates for three consecutive quarters. Key financials show robust profitability with a net income margin of 55.07% and ROE of 37.73%. Recent news highlights WDC's position in the AI-driven memory and storage rebound, with institutional buying activity noted.
Outlook remains positive given analyst consensus and AI-driven demand, though valuation multiples are elevated. Risks include market volatility and competitive pressures. The consensus price target of $619.07 suggests potential upside, supported by strong institutional sentiment and fundamental improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About 10X Genomics Inc
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The product portfolio of the company includes Chromium Controller, Reagent Kits, 10x Compatible Products, and Informatics Software among others. The majority of its revenue is generated from consumables.
Read more on TXG →About Western Digital Corp
Western Digital is a vertically integrated supplier of data storage solutions, spanning both hard disk drives and solid-state drives. In the HDD market it forms a practical duopoly with Seagate, and it is the largest global producer of NAND flash chips for SSDs in a joint venture with competitor Kioxia.
Read more on WDC →
